Back to today’s briefing

Story perspectives

Breakthrough Drug NVG-291 Restores Movement After Paralysis

10/5/2025

37 6

Summary

Story summary

Experimental drug NVG-291 shows potential to improve movement after spinal cord injury.
Trial participant Larry Williams, paralyzed after a biking accident, reports recovery.
He now walks 10 meters in 15 seconds, down from 45.
He can swim laps and perform tasks more easily.
Dr. Monica Perez says NVG-291 blocks signals inhibiting nerve growth, aiding recovery; long-term effects need study.

1 of 1

Story summary

Experimental drug NVG-291 shows potential to improve movement after spinal cord injury.
Trial participant Larry Williams, paralyzed after a biking accident, reports recovery.
He now walks 10 meters in 15 seconds, down from 45.
He can swim laps and perform tasks more easily.
Dr. Monica Perez says NVG-291 blocks signals inhibiting nerve growth, aiding recovery; long-term effects need study.